[go: up one dir, main page]

AU2002347314A1 - Vaccine against enteropathogenic and enterohaemorragic escherichia coli - Google Patents

Vaccine against enteropathogenic and enterohaemorragic escherichia coli

Info

Publication number
AU2002347314A1
AU2002347314A1 AU2002347314A AU2002347314A AU2002347314A1 AU 2002347314 A1 AU2002347314 A1 AU 2002347314A1 AU 2002347314 A AU2002347314 A AU 2002347314A AU 2002347314 A AU2002347314 A AU 2002347314A AU 2002347314 A1 AU2002347314 A1 AU 2002347314A1
Authority
AU
Australia
Prior art keywords
enterohaemorragic
escherichia coli
vaccine against
against enteropathogenic
enteropathogenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002347314A
Inventor
Gad Meir Frankel
Stuart Knutton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ip2ipo Innovations Ltd
Original Assignee
Imperial College Innovations Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial College Innovations Ltd filed Critical Imperial College Innovations Ltd
Publication of AU2002347314A1 publication Critical patent/AU2002347314A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/13—Nucleic acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2002347314A 2002-11-29 2002-11-29 Vaccine against enteropathogenic and enterohaemorragic escherichia coli Abandoned AU2002347314A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/GB2002/005374 WO2004050119A1 (en) 2002-11-29 2002-11-29 Vaccine against enteropathogenic and enterohaemorragic escherichia coli

Publications (1)

Publication Number Publication Date
AU2002347314A1 true AU2002347314A1 (en) 2004-06-23

Family

ID=32408032

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002347314A Abandoned AU2002347314A1 (en) 2002-11-29 2002-11-29 Vaccine against enteropathogenic and enterohaemorragic escherichia coli

Country Status (2)

Country Link
AU (1) AU2002347314A1 (en)
WO (1) WO2004050119A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012522522A (en) * 2009-04-06 2012-09-27 ユニバーシティー オヴ サスカチュワン Methods and compositions for treating and preventing Shiga toxin-producing Escherichia coli infection
CN105821065A (en) * 2016-04-29 2016-08-03 南方医科大学 Double-antigen recombinant protein and preparation method and application thereof
CN109242327B (en) * 2018-09-20 2021-06-15 姜龙训 Vaccine management system

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2389625T3 (en) * 1996-04-23 2012-10-29 The University Of British Columbia Vaccine comprising the EspA protein associated with pathogenic Escherichia coli
WO2002053181A1 (en) * 2001-01-04 2002-07-11 University Of Saskatchewan Enterohemorragic escherichia coli vaccine

Also Published As

Publication number Publication date
WO2004050119A1 (en) 2004-06-17

Similar Documents

Publication Publication Date Title
AU2002340999A1 (en) Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
AU2003301026A1 (en) Medical wraps
AU2003284472A1 (en) Warm poultice
AU2003254844A1 (en) Substituted amino compounds and use thereof
AU2003281044A1 (en) Pyrrolopyridine derivative and use thereof
AU2003255645A1 (en) Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
AU2003269018A1 (en) Acylaminothiazole derivatives, preparation and therapeutic use thereof
AU2003249722A1 (en) Therapeutic amides
AU2003281691A1 (en) Furoisoquinoline derivative and use thereof
AU2002347314A1 (en) Vaccine against enteropathogenic and enterohaemorragic escherichia coli
PL375309A1 (en) Acyloxypyrrolidine derivatives, preparation and therapeutic use thereof
AU2002358574A1 (en) Therapeutic benzamide derivatives
AUPR606401A0 (en) Pyrazolopyridine compound and pharmaceutical use thereof
AUPR916301A0 (en) Pyrazolopyridine compound and pharmaceutical use thereof
AU2002229870A1 (en) Mikanolide derivatives, their preparation and therapeutic uses
AU2003900495A0 (en) Aroylhydrazone derivatives and therapeutic uses thereof
AU2002358076A1 (en) Therapeutic benzamide derivatives
AU2002308105A1 (en) Benzoaxathiepin derivatives and their use as medicines
AUPR548601A0 (en) Pyrazolopyrazinecompound and pharmaceutical use thereof
AU2002315309A1 (en) Vaccine against tuberculosis
AUPS243002A0 (en) Therapeutic target and uses thereof
AU2003287840A1 (en) Arylthioetherpyrimidine and aryloxyetherpyrimidine derivatives and their therapeutic uses
AU2003213959A1 (en) Adenine phosphoryltransferase from escherichia coli
AU2003209845A1 (en) Naphthylsemicarbazone, naphthylhydrazone, naphthylthiosemicarbazone, and naphthylthiohydrazone compounds and therapeutic use thereof
AU2002335433A1 (en) Drug transporter and use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase